October 27, 2011 — Sulodexide does not have a renoprotective effect in patients with type 2 diabetes, renal impairment, or macroalbuminuria, according to results of a large, new, clinical trial. These ...

PADUA, ITALY — For patients with first-time unprovoked venous thromboembolism (VTE), oral sulodexide may help stave off future flare-ups without causing serious safety risks, suggests new research [1] ...

Sulonex (sulodexide oral gelcap) belongs to a proposed new class of nephroprotective, or kidney protecting, drugs, known as the glycosaminoglycans. A variety of members of this chemical family have ...

The study included 34 patients (24 women and 10 men; age, 27–55 years). The mean (SD) duration of RS symptoms prior to the baseline examination was 11 (10) years. The inclusion criterion was the ...

Sulodexide, a glycosaminoglycan, could reduce albuminuria in diabetic patients. The aim of this study was to determine whether sulodexide could be used to treat chronic kidney failure in rats. Sixty ...